CONTOLI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 9.458
EU - Europa 2.506
AS - Asia 1.820
OC - Oceania 17
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 3
Totale 13.820
Nazione #
US - Stati Uniti d'America 9.424
CN - Cina 810
IT - Italia 733
SG - Singapore 535
UA - Ucraina 448
DE - Germania 364
TR - Turchia 285
GB - Regno Unito 250
SE - Svezia 208
FI - Finlandia 184
PL - Polonia 147
ID - Indonesia 126
FR - Francia 56
CA - Canada 32
BE - Belgio 26
NL - Olanda 22
CZ - Repubblica Ceca 19
VN - Vietnam 19
AU - Australia 12
LT - Lituania 12
IN - India 11
HK - Hong Kong 9
BR - Brasile 7
JP - Giappone 7
ES - Italia 6
NZ - Nuova Zelanda 5
RU - Federazione Russa 5
EU - Europa 4
HU - Ungheria 4
IR - Iran 4
MK - Macedonia 4
AT - Austria 3
IE - Irlanda 3
RO - Romania 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
CH - Svizzera 2
EG - Egitto 2
PT - Portogallo 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CL - Cile 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MX - Messico 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
VE - Venezuela 1
Totale 13.820
Città #
Fairfield 1.248
Woodbridge 1.044
Houston 956
Ashburn 604
Santa Clara 587
Jacksonville 556
Chandler 537
Ann Arbor 507
Wilmington 488
Seattle 483
Singapore 437
Cambridge 426
Izmir 186
Nanjing 177
Princeton 169
Ferrara 165
Warsaw 145
Jakarta 125
Beijing 124
Milan 120
New York 103
San Diego 103
Boardman 89
Munich 89
Shanghai 83
Helsinki 72
Addison 64
Los Angeles 62
Dearborn 55
Nanchang 49
Shenyang 47
London 40
Mountain View 35
Washington 35
Tianjin 31
Changsha 30
Hebei 30
Jiaxing 29
Redwood City 28
Brussels 26
Falls Church 26
Bologna 24
Frankfurt am Main 23
Jinan 22
Norwalk 22
Bremen 19
Orange 18
Rome 18
Toronto 17
Dong Ket 16
Kunming 16
Brno 15
Guangzhou 15
Council Bluffs 13
Lappeenranta 13
Taizhou 13
Zhengzhou 13
Des Moines 12
Auburn Hills 11
Ningbo 11
Augusta 10
San Mateo 10
Verona 10
Chicago 9
Parma 9
Ferrara di Monte Baldo 8
Florence 8
Lanzhou 8
Paris 8
Redmond 8
Hong Kong 7
Ottawa 7
Catania 6
Hefei 6
Indiana 6
Istanbul 6
Naples 6
Napoli 6
Philadelphia 6
Reggio Nell'emilia 6
Tappahannock 6
Vicenza 6
Changchun 5
Kilburn 5
Beauharnois 4
Budapest 4
Hounslow 4
Islington 4
Leawood 4
Lecco 4
Monmouth Junction 4
Nuremberg 4
Olomouc 4
Padova 4
Palermo 4
Rimini 4
Tokyo 4
Wuhan 4
Albano 3
Auckland 3
Totale 10.755
Nome #
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 313
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 198
Respiratory muscle training with normocapnic hyperpnea improves ventilatory pattern and thoracoabdominal coordination, and reduces oxygen desaturation during endurance exercise testing in COPD patients 193
The contribution of small-Airway abnormalities in chronic obstructive pulmonary disease clinical manifestations: More than a functional issue 192
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 178
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 177
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 169
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 168
Targeting Th2 cells in asthmatic airways 149
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 149
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 143
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 142
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio. 141
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 141
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 141
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 135
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 135
Models of infection and exacerbations in COPD. 134
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 134
Rhinovirus vaccination: the case against 130
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 128
Physiologic Evaluation of Ventilation Perfusion Mismatch and Respiratory Mechanics at Different Positive End-expiratory Pressure in Patients Undergoing Protective One-lung Ventilation 127
null 126
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 126
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 123
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 121
null 121
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 120
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 120
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. 118
Reducing Agents Decrease the Oxidative Burst and Improve Clinical Outcomes in COPD Patients: A Randomised Controlled Trial on the Effects of Sulphurous Thermal Water Inhalation. 116
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 115
null 114
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 113
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 111
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 110
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 108
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 107
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): Focus on virus induced exacerbations 106
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 105
IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma 105
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 105
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 104
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 104
Small airway disease in asthma: pathophysiological and diagnostic considerations 103
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 102
null 102
When asthma diagnosis becomes a challenge 101
Anti-SARS-Cov-2 IgA response in tears of COVID-19 patients 101
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 101
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 100
γδT cells suppress inflammation and disease during rhinovirus-induced asthma exacerbations. 100
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 100
Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease 99
Models of respiratory infections: Virus-induced asthma exacerbations and beyond 98
Is Peripheral Oxygen Saturation a Reliable Predictor of Upper Airways Air-Flow Limitation? 98
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 98
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 97
Mechanisms of respiratory virus-induced asthma exacerbations 96
ELEMENTI DI VALUTAZIONE E DIAGNOSTICA FUNZIONALE DELL’APPARATO RESPIRATORIO 96
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 96
Increased deposition of activated complement in peripheral lung vessels of smokers 95
Interleukin-4 Modulates Rhinovirus Replication and Antiviral Immune Response in Respiratory Epithelial Cells 94
Rhinovirus-induced bronchial mucosal inflammatory response in asthma 92
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy 92
Cellule staminali e patologia polmonare dell’adulto 91
Neutrophil adhesion molecules in experimental rhinovirus infection in COPD. 91
null 90
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 89
A simple method for home exercise training in patients with chronic obstructive pulmonary disease: One-year study 88
Rhinovirus-induced interferon production in asthma 88
null 88
Bronchial epithelial cells from asthmatic children have a deficient innate immune response to rhinovirus infection 87
null 87
Do small airway abnormalities characterize asthma phenotypes? In search of proof. 86
Asthma: A Chronic Infectious Disease? 86
Effects of aclidinium on determinants of COPD severity: Symptoms and quality of life 86
Effects of Anti-IL-5 on Virus-induced Exacerbation in Asthma Light and Shadow 84
Pathophysiology of viral-induced exacerbations of COPD 83
null 83
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine 83
Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up 83
Interactions of airway pathogens and inflammatory processes 83
Midazolam in flexible bronchoscopy premedication: effects on patient-related and procedure-related outcomes. 82
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease 82
Deficient immune response to viral infections in children predicts later Asthma persistence 82
The small airways and distal lung compartment in asthma and COPD: A time for reappraisal 81
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 81
Interactions of airway pathogens and inflammatory processes 79
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 78
Update in asthma 2016 77
Disease awareness in patients with COPD: measurement and extent 76
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD 73
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study 72
Role of deficient type III interferon-lambda production in asthma exacerbations 71
null 71
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 71
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 70
null 70
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 69
Totale 10.917
Categoria #
all - tutte 80.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.478
Totale 83.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.232 0 0 0 0 0 0 282 294 246 249 86 75
2020/20212.212 126 132 170 247 155 181 103 261 74 305 266 192
2021/20221.529 74 125 108 140 56 80 85 98 65 116 160 422
2022/20231.438 185 62 69 145 205 192 107 117 174 26 104 52
2023/2024980 74 107 48 29 59 170 38 68 34 34 49 270
2024/20251.781 100 107 363 166 530 446 69 0 0 0 0 0
Totale 14.204